Cover Image

TACC3 overexpression in cholangiocarcinoma correlates with poor prognosis and is a potential anti-cancer molecular drug target for HDAC inhibitors

https://doi.org/10.18632/oncotarget.12254 Jun-chuang He, Wei Yao, Jian-ming Wang, Peter Schemmer, Yan Yang, Yan Liu, Ya-wei Qian, Wei-peng Qi, Jian Zhang, Qi Shen, Tao Yang

Saved in:
Bibliographic Details
Main Authors: He, Jun-chuang (Author) , Yao, Wei (Author) , Wang, Jian-ming (Author) , Schemmer, Peter (Author) , Yang, Yan (Author) , Liu, Yan (Author) , Qian, Ya-wei (Author) , Qi, Wei-peng (Author) , Zhang, Jian (Author) , Shen, Qi (Author) , Yang, Tao (Author)
Format: Article (Journal)
Language:English
Published: September 26, 2016
In: OncoTarget
Year: 2016, Volume: 7, Issue: 46, Pages: 75441-75456
ISSN:1949-2553
DOI:10.18632/oncotarget.12254
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.18632/oncotarget.12254
Verlag, lizenzpflichtig, Volltext: https://www.oncotarget.com/article/12254/text/
Get full text
Author Notes:Jun-chuang He, Wei Yao, Jian-ming Wang, Peter Schemmer, Yan Yang, Yan Liu, Ya-wei Qian, Wei-peng Qi, Jian Zhang, Qi Shen, Tao Yang
Description
Summary:https://doi.org/10.18632/oncotarget.12254 Jun-chuang He, Wei Yao, Jian-ming Wang, Peter Schemmer, Yan Yang, Yan Liu, Ya-wei Qian, Wei-peng Qi, Jian Zhang, Qi Shen, Tao Yang
Item Description:Gesehen am 07.05.2020
Physical Description:Online Resource
ISSN:1949-2553
DOI:10.18632/oncotarget.12254

Similar Items